Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carisma Therapeutics

0.4006
-0.0058-1.43%
Pre-market: 0.40900.0084+2.10%04:35 EDT
Volume:858.65K
Turnover:361.08K
Market Cap:16.74M
PE:-0.33
High:0.4399
Open:0.4200
Low:0.4006
Close:0.4064
Loading ...

Carisma Therapeutics Announces Merger with OrthoCellix

TIPRANKS
·
24 Jun

BRIEF-Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement

Reuters
·
23 Jun

Ocugen Inc. and Carisma Therapeutics Finalize Merger to Advance NeoCart® Regenerative Therapy for Knee Cartilage Repair

Reuters
·
23 Jun

Carisma Therapeutics Inc - Orthocellix Stockholder to Own 90% of Combined Company Post-Merger

THOMSON REUTERS
·
23 Jun

Carisma Therapeutics Inc - Orthocellix to Merge Into Wholly-Owned Subsidiary of Carisma

THOMSON REUTERS
·
23 Jun

Carisma Therapeutics: to Issue to Pre-Merger Orthocellix Stockholder Shares of Co's Common Stock as Merger Consideration

THOMSON REUTERS
·
23 Jun

Carisma Therapeutics Inc - to Be Renamed Orthocellix and Trade Under Ticker Oclx

THOMSON REUTERS
·
23 Jun

Carisma Therapeutics and Orthocellix Enter Into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases

THOMSON REUTERS
·
23 Jun

Carmila SAS (CARM) was downgraded to a Sell Rating at Kempen & Co

TIPRANKS
·
20 Jun

Carisma Therapeutics Granted Extended Time to Meet Nasdaq Listing Standards Amid Ongoing Delisting Concerns

Reuters
·
12 Jun

Carisma Therapeutics Stock (CARM) Retreats 35% After a Massive Rally

TIPRANKS
·
11 Jun

Is the 250% Carisma Therapeutics Stock (CARM) Surge a Sucker’s Rally?

TIPRANKS
·
10 Jun

Kepler Capital Remains a Buy on Carmila SAS (CARM)

TIPRANKS
·
06 Jun

Carisma Therapeutics Reports Q1 2025 Financial Results

TIPRANKS
·
03 Jun

Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Carisma Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
05 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
03 Apr

Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
02 Apr

Carisma Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
01 Apr